1. Home
  2. ELSE vs PHIO Comparison

ELSE vs PHIO Comparison

Compare ELSE & PHIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Electro-Sensors Inc.

ELSE

Electro-Sensors Inc.

N/A

Current Price

$4.48

Market Cap

15.5M

Sector

Industrials

ML Signal

N/A

Logo Phio Pharmaceuticals Corp.

PHIO

Phio Pharmaceuticals Corp.

N/A

Current Price

$1.25

Market Cap

14.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ELSE
PHIO
Founded
1968
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.5M
14.6M
IPO Year
1995
2011

Fundamental Metrics

Financial Performance
Metric
ELSE
PHIO
Price
$4.48
$1.25
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$10.67
AVG Volume (30 Days)
1.1K
393.0K
Earning Date
05-11-2026
03-05-2026
Dividend Yield
N/A
N/A
EPS Growth
62.50
N/A
EPS
0.06
N/A
Revenue
$9,373,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$74.17
N/A
Revenue Growth
9.56
N/A
52 Week Low
$3.65
$0.81
52 Week High
$5.29
$4.19

Technical Indicators

Market Signals
Indicator
ELSE
PHIO
Relative Strength Index (RSI) 56.07 54.71
Support Level $4.08 $0.99
Resistance Level $4.72 $1.43
Average True Range (ATR) 0.06 0.08
MACD 0.02 0.00
Stochastic Oscillator 76.56 62.94

Price Performance

Historical Comparison
ELSE
PHIO

About ELSE Electro-Sensors Inc.

Electro-Sensors Inc manufactures and sells industrial production monitoring and process control systems. It manufactures a complete line of monitoring and control systems for a wide range of industrial machine applications. The systems measure machine production and operation rates, as well as regulate the speed of related machines in production processes. Its products include motor drive control, position monitors, sensor targets, signal conditioners, speed sensors, speed switches, tachometers, temperature sensors, vibration monitors, etc.

About PHIO Phio Pharmaceuticals Corp.

Phio Pharmaceuticals Corp is a clinical-stage biopharmaceutical company whose proprietary INTASYL small-interfering RNA gene silencing technology is designed to make immune cells more effective in killing tumor cells. Its pipeline programs are PH-762 and PH-894. The group is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems. It is committed to discovering and developing cancer treatments for patients by creating new pathways toward a cancer-free future. The Company operates with a single operating segment, the Clinical segment, and all assets are located in the United States.

Share on Social Networks: